Corona Remedies will open its ₹655.37-crore initial public offering on 8 December, closing on 10 December.
The IPO is entirely an Offer for Sale, with promoters and existing investors selling 61.7 lakh shares. The price band has been set at ₹1,008–₹1,062 per share.
Retail investors can bid for a minimum lot of 14 shares, costing around ₹14,868 at the upper band.
Quotas are split as 50% for institutional buyers, 35% for retail, and 15% for NIIs. As no fresh shares are being issued, the company will not receive new capital from the offer.